APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Disease Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pet Disease Drugs Industry Growth and Trends Forecast to 2032

22 December 2025123 pages

Choose your research edition.

Industry ResearchPet Disease Drugs Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Disease Drugs Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Pet Disease Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Disease Drugs Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Disease Drugs Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Pet Disease Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Disease Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Disease Drugs include Zoetis, Merck & Co., Inc., Zuche Pharmaceuticals, Virbac, Vetoquinol S.A., VETINDIA Pharmaceuticals, SOUND Technologies, SeQuent Scientific and Richter Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pet Disease Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pet Disease Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pet Disease Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pet Disease Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pet Disease Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pet Disease Drugs Market by Company

Zoetis

Merck & Co., Inc.

Zuche Pharmaceuticals

Virbac

Vetoquinol S.A.

VETINDIA Pharmaceuticals

SOUND Technologies

SeQuent Scientific

Richter Pharma

Ourofino Animal Health

Norbrook Laboratories

Multi Radiance Medical

Morvel Laboratories

LABINDIA Healthcare

K-Laser USA

IRM Enterprises

Fidelis Animal Health

Elanco Animal Health

Dechra Pharmaceuticals

Chanelle Pharma

Ceva

Century Pharmaceuticals

Calier

Boehringer Ingelheim

Bimeda

Avazzia

Assisi Animal Health

Ashish Life Science

Pet Disease Drugs Segment by Type

Analgesics

Anti-inflammatory

Parasiticides

Anti-infectives

Others

Pet Disease Drugs Segment by Application

Behavioral Diseases

Pain

Dermatologic Diseases

Orthopedic Diseases

Infectious Diseases

Other

Pet Disease Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Disease Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Disease Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Disease Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Disease Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pet Disease Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Analgesics Table 2. Major Company of Anti-inflammatory Table 3. Major Company of Parasiticides Table 4. Major Company of Anti-infectives Table 5. Major Company of Others Table 6. Global Pet Disease Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 8. Global Pet Disease Drugs Sales Market Share in Volume by Type (2021-2026) Table 9. Global Pet Disease Drugs Sales by Type (2021-2026) & (US$ Million) Table 10. Global Pet Disease Drugs Sales Market Share in Value by Type (2021-2026) Table 11. Global Pet Disease Drugs Price by Type (2021-2026) & (US$/unit) Table 12. Global Pet Disease Drugs Sales by Type (2027-2032) & (k units) Table 13. Global Pet Disease Drugs Sales Market Share in Volume by Type (2027-2032) Table 14. Global Pet Disease Drugs Sales by Type (2027-2032) & (US$ Million) Table 15. Global Pet Disease Drugs Sales Market Share in Value by Type (2027-2032) Table 16. Global Pet Disease Drugs Price by Type (2027-2032) & (US$/unit) Table 17. North America Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 18. North America Pet Disease Drugs Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 20. Europe Pet Disease Drugs Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Pet Disease Drugs Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 24. Latin America Pet Disease Drugs Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Pet Disease Drugs Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Pet Disease Drugs Sales by Type (2021-2026) & (US$ Million) Table 27. Pet Disease Drugs Industry Trends Table 28. Pet Disease Drugs Industry Drivers Table 29. Pet Disease Drugs Industry Opportunities and Challenges Table 30. Pet Disease Drugs Industry Restraints Table 31. Global Pet Disease Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Pet Disease Drugs Revenue Market Share by Company (2021-2026) Table 33. Global Pet Disease Drugs Sales by Company (2021-2026) & (k units) Table 34. Global Pet Disease Drugs Sales Share by Company (2021-2026) Table 35. Global Pet Disease Drugs Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Pet Disease Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Pet Disease Drugs Major Company Production Sites and Headquarters Table 38. Global Pet Disease Drugs Company, Product Type & Application Table 39. Global Pet Disease Drugs Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Pet Disease Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Pet Disease Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Pet Disease Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Pet Disease Drugs Sales Market Share in Volume by Region (2021-2026) Table 45. Global Pet Disease Drugs Sales by Region (2021-2026) & (US$ Million) Table 46. Global Pet Disease Drugs Sales Market Share in Value by Region (2021-2026) Table 47. Global Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Pet Disease Drugs Sales by Region (2027-2032) & (k units) Table 49. Global Pet Disease Drugs Sales Market Share in Volume by Region (2027-2032) Table 50. Global Pet Disease Drugs Sales by Region (2027-2032) & (US$ Million) Table 51. Global Pet Disease Drugs Sales Market Share in Value by Region (2027-2032) Table 52. Global Pet Disease Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Pet Disease Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 55. Global Pet Disease Drugs Sales Market Share in Volume by Application (2021-2026) Table 56. Global Pet Disease Drugs Sales by Application (2021-2026) & (US$ Million) Table 57. Global Pet Disease Drugs Sales Market Share in Value by Application (2021-2026) Table 58. Global Pet Disease Drugs Price by Application (2021-2026) & (US$/unit) Table 59. Global Pet Disease Drugs Sales by Application (2027-2032) & (k units) Table 60. Global Pet Disease Drugs Sales Market Share in Volume by Application (2027-2032) Table 61. Global Pet Disease Drugs Sales by Application (2027-2032) & (US$ Million) Table 62. Global Pet Disease Drugs Sales Market Share in Value by Application (2027-2032) Table 63. Global Pet Disease Drugs Price by Application (2027-2032) & (US$/unit) Table 64. North America Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 65. North America Pet Disease Drugs Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 67. Europe Pet Disease Drugs Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Pet Disease Drugs Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 71. Latin America Pet Disease Drugs Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Pet Disease Drugs Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Pet Disease Drugs Sales by Application (2021-2026) & (US$ Million) Table 74. Zoetis Company Information Table 75. Zoetis Business Overview Table 76. Zoetis Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Zoetis Pet Disease Drugs Product Portfolio Table 78. Zoetis Recent Development Table 79. Merck & Co., Inc. Company Information Table 80. Merck & Co., Inc. Business Overview Table 81. Merck & Co., Inc. Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Merck & Co., Inc. Pet Disease Drugs Product Portfolio Table 83. Merck & Co., Inc. Recent Development Table 84. Zuche Pharmaceuticals Company Information Table 85. Zuche Pharmaceuticals Business Overview Table 86. Zuche Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio Table 88. Zuche Pharmaceuticals Recent Development Table 89. Virbac Company Information Table 90. Virbac Business Overview Table 91. Virbac Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Virbac Pet Disease Drugs Product Portfolio Table 93. Virbac Recent Development Table 94. Vetoquinol S.A. Company Information Table 95. Vetoquinol S.A. Business Overview Table 96. Vetoquinol S.A. Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Vetoquinol S.A. Pet Disease Drugs Product Portfolio Table 98. Vetoquinol S.A. Recent Development Table 99. VETINDIA Pharmaceuticals Company Information Table 100. VETINDIA Pharmaceuticals Business Overview Table 101. VETINDIA Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio Table 103. VETINDIA Pharmaceuticals Recent Development Table 104. SOUND Technologies Company Information Table 105. SOUND Technologies Business Overview Table 106. SOUND Technologies Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. SOUND Technologies Pet Disease Drugs Product Portfolio Table 108. SOUND Technologies Recent Development Table 109. SeQuent Scientific Company Information Table 110. SeQuent Scientific Business Overview Table 111. SeQuent Scientific Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. SeQuent Scientific Pet Disease Drugs Product Portfolio Table 113. SeQuent Scientific Recent Development Table 114. Richter Pharma Company Information Table 115. Richter Pharma Business Overview Table 116. Richter Pharma Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Richter Pharma Pet Disease Drugs Product Portfolio Table 118. Richter Pharma Recent Development Table 119. Ourofino Animal Health Company Information Table 120. Ourofino Animal Health Business Overview Table 121. Ourofino Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Ourofino Animal Health Pet Disease Drugs Product Portfolio Table 123. Ourofino Animal Health Recent Development Table 124. Norbrook Laboratories Company Information Table 125. Norbrook Laboratories Business Overview Table 126. Norbrook Laboratories Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Norbrook Laboratories Pet Disease Drugs Product Portfolio Table 128. Norbrook Laboratories Recent Development Table 129. Multi Radiance Medical Company Information Table 130. Multi Radiance Medical Business Overview Table 131. Multi Radiance Medical Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Multi Radiance Medical Pet Disease Drugs Product Portfolio Table 133. Multi Radiance Medical Recent Development Table 134. Morvel Laboratories Company Information Table 135. Morvel Laboratories Business Overview Table 136. Morvel Laboratories Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Morvel Laboratories Pet Disease Drugs Product Portfolio Table 138. Morvel Laboratories Recent Development Table 139. LABINDIA Healthcare Company Information Table 140. LABINDIA Healthcare Business Overview Table 141. LABINDIA Healthcare Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. LABINDIA Healthcare Pet Disease Drugs Product Portfolio Table 143. LABINDIA Healthcare Recent Development Table 144. K-Laser USA Company Information Table 145. K-Laser USA Business Overview Table 146. K-Laser USA Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 147. K-Laser USA Pet Disease Drugs Product Portfolio Table 148. K-Laser USA Recent Development Table 149. IRM Enterprises Company Information Table 150. IRM Enterprises Business Overview Table 151. IRM Enterprises Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 152. IRM Enterprises Pet Disease Drugs Product Portfolio Table 153. IRM Enterprises Recent Development Table 154. Fidelis Animal Health Company Information Table 155. Fidelis Animal Health Business Overview Table 156. Fidelis Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 157. Fidelis Animal Health Pet Disease Drugs Product Portfolio Table 158. Fidelis Animal Health Recent Development Table 159. Elanco Animal Health Company Information Table 160. Elanco Animal Health Business Overview Table 161. Elanco Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 162. Elanco Animal Health Pet Disease Drugs Product Portfolio Table 163. Elanco Animal Health Recent Development Table 164. Dechra Pharmaceuticals Company Information Table 165. Dechra Pharmaceuticals Business Overview Table 166. Dechra Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 167. Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio Table 168. Dechra Pharmaceuticals Recent Development Table 169. Chanelle Pharma Company Information Table 170. Chanelle Pharma Business Overview Table 171. Chanelle Pharma Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 172. Chanelle Pharma Pet Disease Drugs Product Portfolio Table 173. Chanelle Pharma Recent Development Table 174. Ceva Company Information Table 175. Ceva Business Overview Table 176. Ceva Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 177. Ceva Pet Disease Drugs Product Portfolio Table 178. Ceva Recent Development Table 179. Century Pharmaceuticals Company Information Table 180. Century Pharmaceuticals Business Overview Table 181. Century Pharmaceuticals Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 182. Century Pharmaceuticals Pet Disease Drugs Product Portfolio Table 183. Century Pharmaceuticals Recent Development Table 184. Calier Company Information Table 185. Calier Business Overview Table 186. Calier Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 187. Calier Pet Disease Drugs Product Portfolio Table 188. Calier Recent Development Table 189. Boehringer Ingelheim Company Information Table 190. Boehringer Ingelheim Business Overview Table 191. Boehringer Ingelheim Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 192. Boehringer Ingelheim Pet Disease Drugs Product Portfolio Table 193. Boehringer Ingelheim Recent Development Table 194. Bimeda Company Information Table 195. Bimeda Business Overview Table 196. Bimeda Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 197. Bimeda Pet Disease Drugs Product Portfolio Table 198. Bimeda Recent Development Table 199. Avazzia Company Information Table 200. Avazzia Business Overview Table 201. Avazzia Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 202. Avazzia Pet Disease Drugs Product Portfolio Table 203. Avazzia Recent Development Table 204. Assisi Animal Health Company Information Table 205. Assisi Animal Health Business Overview Table 206. Assisi Animal Health Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 207. Assisi Animal Health Pet Disease Drugs Product Portfolio Table 208. Assisi Animal Health Recent Development Table 209. Ashish Life Science Company Information Table 210. Ashish Life Science Business Overview Table 211. Ashish Life Science Pet Disease Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 212. Ashish Life Science Pet Disease Drugs Product Portfolio Table 213. Ashish Life Science Recent Development Table 214. North America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 215. North America Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 216. North America Pet Disease Drugs Sales Market Share by Country (2021-2026) Table 217. North America Pet Disease Drugs Sales Forecast by Country (2027-2032) & (k units) Table 218. North America Pet Disease Drugs Sales Market Share Forecast by Country (2027-2032) Table 219. North America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 220. North America Pet Disease Drugs Market Size by Country (2021-2026) & (US$ Million) Table 221. North America Pet Disease Drugs Market Share by Country (2021-2026) Table 222. North America Pet Disease Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 223. North America Pet Disease Drugs Market Share Forecast by Country (2027-2032) Table 224. Europe Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 225. Europe Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 226. Europe Pet Disease Drugs Sales Market Share by Country (2021-2026) Table 227. Europe Pet Disease Drugs Sales Forecast by Country (2027-2032) & (k units) Table 228. Europe Pet Disease Drugs Sales Market Share Forecast by Country (2027-2032) Table 229. Europe Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 230. Europe Pet Disease Drugs Market Size by Country (2021-2026) & (US$ Million) Table 231. Europe Pet Disease Drugs Market Share by Country (2021-2026) Table 232. Europe Pet Disease Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 233. Europe Pet Disease Drugs Market Share Forecast by Country (2027-2032) Table 234. Asia-Pacific Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 235. Asia-Pacific Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 236. Asia-Pacific Pet Disease Drugs Sales Market Share by Country (2021-2026) Table 237. Asia-Pacific Pet Disease Drugs Sales Forecast by Country (2027-2032) & (k units) Table 238. Asia-Pacific Pet Disease Drugs Sales Market Share Forecast by Country (2027-2032) Table 239. Asia-Pacific Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 240. Asia-Pacific Pet Disease Drugs Market Size by Country (2021-2026) & (US$ Million) Table 241. Asia-Pacific Pet Disease Drugs Market Share by Country (2021-2026) Table 242. Asia-Pacific Pet Disease Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 243. Asia-Pacific Pet Disease Drugs Market Share Forecast by Country (2027-2032) Table 244. Latin America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 245. Latin America Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 246. Latin America Pet Disease Drugs Sales Market Share by Country (2021-2026) Table 247. Latin America Pet Disease Drugs Sales Forecast by Country (2027-2032) & (k units) Table 248. Latin America Pet Disease Drugs Sales Market Share Forecast by Country (2027-2032) Table 249. Latin America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 250. Latin America Pet Disease Drugs Market Size by Country (2021-2026) & (US$ Million) Table 251. Latin America Pet Disease Drugs Market Share by Country (2021-2026) Table 252. Latin America Pet Disease Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 253. Latin America Pet Disease Drugs Market Share Forecast by Country (2027-2032) Table 254. Middle East and Africa Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 255. Middle East and Africa Pet Disease Drugs Sales by Country (2021-2026) & (k units) Table 256. Middle East and Africa Pet Disease Drugs Sales Market Share by Country (2021-2026) Table 257. Middle East and Africa Pet Disease Drugs Sales Forecast by Country (2027-2032) & (k units) Table 258. Middle East and Africa Pet Disease Drugs Sales Market Share Forecast by Country (2027-2032) Table 259. Middle East and Africa Pet Disease Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 260. Middle East and Africa Pet Disease Drugs Market Size by Country (2021-2026) & (US$ Million) Table 261. Middle East and Africa Pet Disease Drugs Market Share by Country (2021-2026) Table 262. Middle East and Africa Pet Disease Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 263. Middle East and Africa Pet Disease Drugs Market Share Forecast by Country (2027-2032) Table 264. Key Raw Materials Table 265. Raw Materials Key Suppliers Table 266. Pet Disease Drugs Distributors List Table 267. Pet Disease Drugs Customers List Table 268. Research Programs/Design for This Report Table 269. Authors List of This Report Table 270. Secondary Sources Table 271. Primary Sources List of Figures Figure 1. Pet Disease Drugs Image Figure 2. Global Pet Disease Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Disease Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Disease Drugs Sales (2021-2032) & (k units) Figure 5. Analgesics Image Figure 6. Global Analgesics Sales YoY Growth (2021-2032) & (k units) Figure 7. Anti-inflammatory Image Figure 8. Global Anti-inflammatory Sales YoY Growth (2021-2032) & (k units) Figure 9. Parasiticides Image Figure 10. Global Parasiticides Sales YoY Growth (2021-2032) & (k units) Figure 11. Anti-infectives Image Figure 12. Global Anti-infectives Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Pet Disease Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Pet Disease Drugs Market Share by Type 2025 VS 2032 Figure 17. North America Pet Disease Drugs Sales Market Share in Volume by Type in 2025 Figure 18. North America Pet Disease Drugs Sales Market Share in Value by Type in 2025 Figure 19. Europe Pet Disease Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Europe Pet Disease Drugs Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Pet Disease Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Pet Disease Drugs Sales Market Share in Value by Type in 2025 Figure 23. Latin America Pet Disease Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Pet Disease Drugs Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Pet Disease Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Pet Disease Drugs Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Pet Disease Drugs Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Behavioral Diseases Image Figure 30. Global Behavioral Diseases Sales YoY Growth (2021-2032) & (k units) Figure 31. Pain Image Figure 32. Global Pain Sales YoY Growth (2021-2032) & (k units) Figure 33. Dermatologic Diseases Image Figure 34. Global Dermatologic Diseases Sales YoY Growth (2021-2032) & (k units) Figure 35. Orthopedic Diseases Image Figure 36. Global Orthopedic Diseases Sales YoY Growth (2021-2032) & (k units) Figure 37. Infectious Diseases Image Figure 38. Global Infectious Diseases Sales YoY Growth (2021-2032) & (k units) Figure 39. Other Image Figure 40. Global Other Sales YoY Growth (2021-2032) & (k units) Figure 41. Global Pet Disease Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Pet Disease Drugs Market Share by Application 2025 VS 2032 Figure 43. North America Pet Disease Drugs Sales Market Share in Volume by Application in 2025 Figure 44. North America Pet Disease Drugs Sales Market Share in Value by Application in 2025 Figure 45. Europe Pet Disease Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Europe Pet Disease Drugs Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Pet Disease Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Pet Disease Drugs Sales Market Share in Value by Application in 2025 Figure 49. Latin America Pet Disease Drugs Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Pet Disease Drugs Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Pet Disease Drugs Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Pet Disease Drugs Sales Market Share in Value by Application in 2025 Figure 53. North America Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. North America Pet Disease Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Pet Disease Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Europe Pet Disease Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Pet Disease Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Asia-Pacific Pet Disease Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Pet Disease Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Latin America Pet Disease Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Pet Disease Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Pet Disease Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 70. Middle East and Africa Pet Disease Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Pet Disease Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Pet Disease Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Pet Disease Drugs Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Pet Disease Drugs Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Analgesics
  • Anti-inflammatory
  • Parasiticides
  • Anti-infectives
  • Others
Applications
  • Behavioral Diseases
  • Pain
  • Dermatologic Diseases
  • Orthopedic Diseases
  • Infectious Diseases
  • Other
Companies covered
  • Zoetis
  • Merck & Co., Inc.
  • Zuche Pharmaceuticals
  • Virbac
  • Vetoquinol S.A.
  • VETINDIA Pharmaceuticals
  • SOUND Technologies
  • SeQuent Scientific
  • Richter Pharma
  • Ourofino Animal Health
  • Norbrook Laboratories
  • Multi Radiance Medical
  • Morvel Laboratories
  • LABINDIA Healthcare
  • K-Laser USA
  • IRM Enterprises
  • Fidelis Animal Health
  • Elanco Animal Health
  • Dechra Pharmaceuticals
  • Chanelle Pharma
  • Ceva
  • Century Pharmaceuticals
  • Calier
  • Boehringer Ingelheim
  • Bimeda
  • Avazzia
  • Assisi Animal Health
  • Ashish Life Science

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pet Disease Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pet Disease Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pet Disease Drugs Market by Type
  6. 1.3.1 Analgesics
  7. 1.3.2 Anti-inflammatory
  8. 1.3.3 Parasiticides
  9. 1.3.4 Anti-infectives
  10. 1.3.5 Others
  11. 1.4 Global Pet Disease Drugs Market Size by Type
  12. 1.4.1 Global Pet Disease Drugs Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Pet Disease Drugs Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Pet Disease Drugs Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Pet Disease Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Pet Disease Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Pet Disease Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Pet Disease Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Pet Disease Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pet Disease Drugs Industry Trends
  2. 2.2 Pet Disease Drugs Industry Drivers
  3. 2.3 Pet Disease Drugs Industry Opportunities and Challenges
  4. 2.4 Pet Disease Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pet Disease Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Pet Disease Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Pet Disease Drugs Price (2021-2026)
  4. 3.4 Global Pet Disease Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Disease Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Pet Disease Drugs Company, Product Type & Application
  7. 3.7 Global Pet Disease Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Disease Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Disease Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Disease Drugs Tier 1, Tier 2, and Tier 3
4 Pet Disease Drugs Regional Status and Outlook
  1. 4.1 Global Pet Disease Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pet Disease Drugs Historic Market Size by Region
  3. 4.2.1 Global Pet Disease Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pet Disease Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pet Disease Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pet Disease Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Pet Disease Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pet Disease Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pet Disease Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pet Disease Drugs by Application
  1. 5.1 Pet Disease Drugs Market by Application
  2. 5.1.1 Behavioral Diseases
  3. 5.1.2 Pain
  4. 5.1.3 Dermatologic Diseases
  5. 5.1.4 Orthopedic Diseases
  6. 5.1.5 Infectious Diseases
  7. 5.1.6 Other
  8. 5.2 Global Pet Disease Drugs Market Size by Application
  9. 5.2.1 Global Pet Disease Drugs Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Pet Disease Drugs Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Pet Disease Drugs Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Pet Disease Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Pet Disease Drugs Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Pet Disease Drugs Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Pet Disease Drugs Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Pet Disease Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zoetis
  2. 6.1.1 Zoetis Company Information
  3. 6.1.2 Zoetis Business Overview
  4. 6.1.3 Zoetis Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zoetis Pet Disease Drugs Product Portfolio
  6. 6.1.5 Zoetis Recent Developments
  7. 6.2 Merck & Co., Inc.
  8. 6.2.1 Merck & Co., Inc. Company Information
  9. 6.2.2 Merck & Co., Inc. Business Overview
  10. 6.2.3 Merck & Co., Inc. Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck & Co., Inc. Pet Disease Drugs Product Portfolio
  12. 6.2.5 Merck & Co., Inc. Recent Developments
  13. 6.3 Zuche Pharmaceuticals
  14. 6.3.1 Zuche Pharmaceuticals Company Information
  15. 6.3.2 Zuche Pharmaceuticals Business Overview
  16. 6.3.3 Zuche Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Zuche Pharmaceuticals Pet Disease Drugs Product Portfolio
  18. 6.3.5 Zuche Pharmaceuticals Recent Developments
  19. 6.4 Virbac
  20. 6.4.1 Virbac Company Information
  21. 6.4.2 Virbac Business Overview
  22. 6.4.3 Virbac Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Virbac Pet Disease Drugs Product Portfolio
  24. 6.4.5 Virbac Recent Developments
  25. 6.5 Vetoquinol S.A.
  26. 6.5.1 Vetoquinol S.A. Company Information
  27. 6.5.2 Vetoquinol S.A. Business Overview
  28. 6.5.3 Vetoquinol S.A. Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vetoquinol S.A. Pet Disease Drugs Product Portfolio
  30. 6.5.5 Vetoquinol S.A. Recent Developments
  31. 6.6 VETINDIA Pharmaceuticals
  32. 6.6.1 VETINDIA Pharmaceuticals Company Information
  33. 6.6.2 VETINDIA Pharmaceuticals Business Overview
  34. 6.6.3 VETINDIA Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 VETINDIA Pharmaceuticals Pet Disease Drugs Product Portfolio
  36. 6.6.5 VETINDIA Pharmaceuticals Recent Developments
  37. 6.7 SOUND Technologies
  38. 6.7.1 SOUND Technologies Company Information
  39. 6.7.2 SOUND Technologies Business Overview
  40. 6.7.3 SOUND Technologies Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 SOUND Technologies Pet Disease Drugs Product Portfolio
  42. 6.7.5 SOUND Technologies Recent Developments
  43. 6.8 SeQuent Scientific
  44. 6.8.1 SeQuent Scientific Company Information
  45. 6.8.2 SeQuent Scientific Business Overview
  46. 6.8.3 SeQuent Scientific Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 SeQuent Scientific Pet Disease Drugs Product Portfolio
  48. 6.8.5 SeQuent Scientific Recent Developments
  49. 6.9 Richter Pharma
  50. 6.9.1 Richter Pharma Company Information
  51. 6.9.2 Richter Pharma Business Overview
  52. 6.9.3 Richter Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Richter Pharma Pet Disease Drugs Product Portfolio
  54. 6.9.5 Richter Pharma Recent Developments
  55. 6.10 Ourofino Animal Health
  56. 6.10.1 Ourofino Animal Health Company Information
  57. 6.10.2 Ourofino Animal Health Business Overview
  58. 6.10.3 Ourofino Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Ourofino Animal Health Pet Disease Drugs Product Portfolio
  60. 6.10.5 Ourofino Animal Health Recent Developments
  61. 6.11 Norbrook Laboratories
  62. 6.11.1 Norbrook Laboratories Company Information
  63. 6.11.2 Norbrook Laboratories Business Overview
  64. 6.11.3 Norbrook Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Norbrook Laboratories Pet Disease Drugs Product Portfolio
  66. 6.11.5 Norbrook Laboratories Recent Developments
  67. 6.12 Multi Radiance Medical
  68. 6.12.1 Multi Radiance Medical Company Information
  69. 6.12.2 Multi Radiance Medical Business Overview
  70. 6.12.3 Multi Radiance Medical Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Multi Radiance Medical Pet Disease Drugs Product Portfolio
  72. 6.12.5 Multi Radiance Medical Recent Developments
  73. 6.13 Morvel Laboratories
  74. 6.13.1 Morvel Laboratories Company Information
  75. 6.13.2 Morvel Laboratories Business Overview
  76. 6.13.3 Morvel Laboratories Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Morvel Laboratories Pet Disease Drugs Product Portfolio
  78. 6.13.5 Morvel Laboratories Recent Developments
  79. 6.14 LABINDIA Healthcare
  80. 6.14.1 LABINDIA Healthcare Company Information
  81. 6.14.2 LABINDIA Healthcare Business Overview
  82. 6.14.3 LABINDIA Healthcare Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 LABINDIA Healthcare Pet Disease Drugs Product Portfolio
  84. 6.14.5 LABINDIA Healthcare Recent Developments
  85. 6.15 K-Laser USA
  86. 6.15.1 K-Laser USA Company Information
  87. 6.15.2 K-Laser USA Business Overview
  88. 6.15.3 K-Laser USA Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 K-Laser USA Pet Disease Drugs Product Portfolio
  90. 6.15.5 K-Laser USA Recent Developments
  91. 6.16 IRM Enterprises
  92. 6.16.1 IRM Enterprises Company Information
  93. 6.16.2 IRM Enterprises Business Overview
  94. 6.16.3 IRM Enterprises Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 IRM Enterprises Pet Disease Drugs Product Portfolio
  96. 6.16.5 IRM Enterprises Recent Developments
  97. 6.17 Fidelis Animal Health
  98. 6.17.1 Fidelis Animal Health Company Information
  99. 6.17.2 Fidelis Animal Health Business Overview
  100. 6.17.3 Fidelis Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Fidelis Animal Health Pet Disease Drugs Product Portfolio
  102. 6.17.5 Fidelis Animal Health Recent Developments
  103. 6.18 Elanco Animal Health
  104. 6.18.1 Elanco Animal Health Company Information
  105. 6.18.2 Elanco Animal Health Business Overview
  106. 6.18.3 Elanco Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Elanco Animal Health Pet Disease Drugs Product Portfolio
  108. 6.18.5 Elanco Animal Health Recent Developments
  109. 6.19 Dechra Pharmaceuticals
  110. 6.19.1 Dechra Pharmaceuticals Company Information
  111. 6.19.2 Dechra Pharmaceuticals Business Overview
  112. 6.19.3 Dechra Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Dechra Pharmaceuticals Pet Disease Drugs Product Portfolio
  114. 6.19.5 Dechra Pharmaceuticals Recent Developments
  115. 6.20 Chanelle Pharma
  116. 6.20.1 Chanelle Pharma Company Information
  117. 6.20.2 Chanelle Pharma Business Overview
  118. 6.20.3 Chanelle Pharma Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Chanelle Pharma Pet Disease Drugs Product Portfolio
  120. 6.20.5 Chanelle Pharma Recent Developments
  121. 6.21 Ceva
  122. 6.21.1 Ceva Company Information
  123. 6.21.2 Ceva Business Overview
  124. 6.21.3 Ceva Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Ceva Pet Disease Drugs Product Portfolio
  126. 6.21.5 Ceva Recent Developments
  127. 6.22 Century Pharmaceuticals
  128. 6.22.1 Century Pharmaceuticals Company Information
  129. 6.22.2 Century Pharmaceuticals Business Overview
  130. 6.22.3 Century Pharmaceuticals Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Century Pharmaceuticals Pet Disease Drugs Product Portfolio
  132. 6.22.5 Century Pharmaceuticals Recent Developments
  133. 6.23 Calier
  134. 6.23.1 Calier Company Information
  135. 6.23.2 Calier Business Overview
  136. 6.23.3 Calier Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Calier Pet Disease Drugs Product Portfolio
  138. 6.23.5 Calier Recent Developments
  139. 6.24 Boehringer Ingelheim
  140. 6.24.1 Boehringer Ingelheim Company Information
  141. 6.24.2 Boehringer Ingelheim Business Overview
  142. 6.24.3 Boehringer Ingelheim Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Boehringer Ingelheim Pet Disease Drugs Product Portfolio
  144. 6.24.5 Boehringer Ingelheim Recent Developments
  145. 6.25 Bimeda
  146. 6.25.1 Bimeda Company Information
  147. 6.25.2 Bimeda Business Overview
  148. 6.25.3 Bimeda Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Bimeda Pet Disease Drugs Product Portfolio
  150. 6.25.5 Bimeda Recent Developments
  151. 6.26 Avazzia
  152. 6.26.1 Avazzia Company Information
  153. 6.26.2 Avazzia Business Overview
  154. 6.26.3 Avazzia Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Avazzia Pet Disease Drugs Product Portfolio
  156. 6.26.5 Avazzia Recent Developments
  157. 6.27 Assisi Animal Health
  158. 6.27.1 Assisi Animal Health Company Information
  159. 6.27.2 Assisi Animal Health Business Overview
  160. 6.27.3 Assisi Animal Health Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 Assisi Animal Health Pet Disease Drugs Product Portfolio
  162. 6.27.5 Assisi Animal Health Recent Developments
  163. 6.28 Ashish Life Science
  164. 6.28.1 Ashish Life Science Company Information
  165. 6.28.2 Ashish Life Science Business Overview
  166. 6.28.3 Ashish Life Science Pet Disease Drugs Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 Ashish Life Science Pet Disease Drugs Product Portfolio
  168. 6.28.5 Ashish Life Science Recent Developments
7 North America by Country
  1. 7.1 North America Pet Disease Drugs Sales by Country
  2. 7.1.1 North America Pet Disease Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pet Disease Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Pet Disease Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pet Disease Drugs Market Size by Country
  6. 7.2.1 North America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pet Disease Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Pet Disease Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pet Disease Drugs Sales by Country
  2. 8.1.1 Europe Pet Disease Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pet Disease Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Pet Disease Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pet Disease Drugs Market Size by Country
  6. 8.2.1 Europe Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pet Disease Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pet Disease Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pet Disease Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Pet Disease Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pet Disease Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pet Disease Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pet Disease Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pet Disease Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pet Disease Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pet Disease Drugs Sales by Country
  2. 10.1.1 South America Pet Disease Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pet Disease Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Pet Disease Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pet Disease Drugs Market Size by Country
  6. 10.2.1 South America Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pet Disease Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Pet Disease Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pet Disease Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Pet Disease Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pet Disease Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pet Disease Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pet Disease Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Pet Disease Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pet Disease Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pet Disease Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pet Disease Drugs Value Chain Analysis
  2. 12.1.1 Pet Disease Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pet Disease Drugs Production Mode & Process
  7. 12.2 Pet Disease Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pet Disease Drugs Distributors
  10. 12.2.3 Pet Disease Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst